Heise T - Search Results

1

Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.

Heise T, Hövelmann U, Brøndsted L, Adrian CL, Nosek L, Haahr H. Heise T, et al. Diabetes Obes Metab. 2015 Jul;17(7):682-8. doi: 10.1111/dom.12468. Epub 2015 May 8. Diabetes Obes Metab. 2015. PMID: 25846340 Free PMC article. Clinical Trial.

2

Action profile of the rapid acting insulin analogue: human insulin B28Asp.

Heinemann L, Heise T, Jorgensen LN, Starke AA. Heinemann L, et al. Among authors: heise t. Diabet Med. 1993 Jul;10(6):535-9. doi: 10.1111/j.1464-5491.1993.tb00116.x. Diabet Med. 1993. PMID: 8365089 Clinical Trial.

3

Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin.

Heinemann L, Heise T, Klepper A, Ampudia J, Bender R, Starke AA. Heinemann L, et al. Among authors: heise t. Diabete Metab. 1995 Dec;21(6):415-9. Diabete Metab. 1995. PMID: 8593922 Clinical Trial.

4

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.

Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, Berger M. Heinemann L, et al. Among authors: heise t. Diabet Med. 1996 Jul;13(7):625-9. doi: 10.1002/(SICI)1096-9136(199607)13:7<625::AID-DIA134>3.0.CO;2-2. Diabet Med. 1996. PMID: 8840095 Clinical Trial.

5

Time-action profile of inhaled insulin.

Heinemann L, Traut T, Heise T. Heinemann L, et al. Among authors: heise t. Diabet Med. 1997 Jan;14(1):63-72. doi: 10.1002/(SICI)1096-9136(199701)14:1<63::AID-DIA298>3.0.CO;2-F. Diabet Med. 1997. PMID: 9017356 Clinical Trial.

6

Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.

Heinemann L, Weyer C, Rave K, Stiefelhagen O, Rauhaus M, Heise T. Heinemann L, et al. Among authors: heise t. Exp Clin Endocrinol Diabetes. 1997;105(3):140-4. doi: 10.1055/s-0029-1211742. Exp Clin Endocrinol Diabetes. 1997. PMID: 9228509 Clinical Trial.

7

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture.

Weyer C, Heise T, Heinemann L. Weyer C, et al. Among authors: heise t. Diabetes Care. 1997 Oct;20(10):1612-4. doi: 10.2337/diacare.20.10.1612. Diabetes Care. 1997. PMID: 9314644 Clinical Trial.

8

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L. Heise T, et al. Diabetes Care. 1998 May;21(5):800-3. doi: 10.2337/diacare.21.5.800. Diabetes Care. 1998. PMID: 9589244 Clinical Trial.

9

Insulin resistance and the effect of insulin on blood pressure in essential hypertension.

Heise T, Magnusson K, Heinemann L, Sawicki PT. Heise T, et al. Hypertension. 1998 Aug;32(2):243-8. doi: 10.1161/01.hyp.32.2.243. Hypertension. 1998. PMID: 9719049 Clinical Trial.

10

Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.

Rave K, Heise T, Weyer C, Herrnberger J, Bender R, Hirschberger S, Heinemann L. Rave K, et al. Among authors: heise t. Diabet Med. 1998 Sep;15(9):747-51. doi: 10.1002/(SICI)1096-9136(199809)15:9<747::AID-DIA664>3.0.CO;2-V. Diabet Med. 1998. PMID: 9737803 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results